DaVita has the Profitability Rank of 9. It has a higher profitability and may stay that way.
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company's business will stay that way. It is based on these factors:
1.
Operating Margin %
2.
Piotroski F-Score
3. Trend of the
Operating Margin % (5-year average). The company with an uptrend profit margin has a higher rank.
4. Consistency of the profitability
5. Predictability Rank
DaVita's Operating Margin % for the quarter that ended in Dec. 2023 was 13.05%. As of today, DaVita's Piotroski F-Score is 7.
Competitive Comparison
For the Medical Care Facilities subindustry, DaVita's Profitability Rank, along with its competitors' market caps and Profitability Rank data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
DaVita Profitability Rank Distribution
For the Healthcare Providers & Services industry and Healthcare sector, DaVita's Profitability Rank distribution charts can be found below:
* The bar in red indicates where DaVita's Profitability Rank falls into.
DaVita Profitability Rank Calculation
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company's business will stay that way.
The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.
DaVita has the Profitability Rank of 9. It has a higher profitability and may stay that way.
Profitability Rank is not directly related to the Financial Strength. But if a company is consistently profitable, its financial strength will be stronger.
Profitability Rank is based on these factors:
1. Operating Margin %
Operating Margin % - also known as operating income margin, operating profit margin and return on sales (ROS) - is the ratio of Operating Income divided by net sales or Revenue, usually presented in percent.
DaVita's Operating Margin % for the quarter that ended in Dec. 2023 is calculated as:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
2. Piotroski F-Score
Good Sign:
Piotroski F-Score is 7, indicates a very healthy situation.
The zones of discrimination were as such:
Good or high score = 8 or 9
Bad or low score = 0 or 1
DaVita has an F-score of 7. It is a good or high score, which usually indicates a very healthy situation.
3. Trend of the Operating Margin % (5-year average). The company with an uptrend profit margin has a higher rank.
Warning Sign:
DaVita Inc operating margin has been in a 5-year decline. The average rate of decline per year is -2.4%.
4. Consistency of the profitability
5. Predictability Rank
DaVita (DaVita) Business Description
Traded in Other Exchanges
Address
2000 16th Street, Denver, CO, USA, 80202
DaVita is the largest provider of dialysis services in the United States, boasting market share that eclipses 35% when measured by both patients and clinics. The firm operates over 3,000 facilities worldwide, mostly in the U.S., and treats over 240,000 patients globally each year. Government payers dominate U.S. dialysis reimbursement. DaVita receives about two thirds of U.S. sales at government (primarily Medicare) reimbursement rates, with the remainder coming from commercial insurers. However, while commercial insurers represented only about 10% of the U.S. patients treated, they represent nearly all of the profits generated by DaVita in the U.S. dialysis business.
Executives
| Christopher Michael Berry |
officer: Chief Accounting Officer |
C/O SONDER HOLDINGS INC., 101 15TH ST., SAN FRANCISCO CA 94103 |
| Kathleen Alyce Waters |
officer: Chief Legal Officer |
C/O DAVITA INC., 2000 16TH STREET, DENVER CO 80202 |
| Wendy Lee Schoppert |
director |
6105 TRENTON LANE NORTH, MINNEAPOLIS MN 55442 |
| Phyllis R Yale |
director |
|
| Javier Rodriguez |
officer: Chief Executive Officer, DKC |
601 HAWAII ST., EL SEGUNDO CA 90245 |
| Barbara J Desoer |
director |
CITIGROUP INC., 388 GREENWICH STREET, 17TH FLOOR, NEW YORK NY 10013 |
| James O Hearty |
officer: Chief Compliance Officer |
2000 16TH STREET, DENVER CO 80202 |
| Charles Berg |
director, officer: Executive Chair, DMG |
48 MONROE TURNPIKE, TRUMBULL CT 06611 |
| John M Nehra |
director |
1119 ST PAUL ST, BALTIMORE MD 21202 |
| Adam H Schechter |
director |
2000 GALLOPING HILL ROAD, KENILWORTH NJ 07033 |
| Michael David Staffieri |
officer: Chief Operating Officer, DKC |
2000 16TH STREET, DENVER CO 80202 |
| Jason M. Hollar |
director |
3333 BEVERLY ROAD, HOFFMAN ESTATES IL 60179 |
| Paula A Price |
director |
ONE CVS DRIVE, WOONSOCKET RI 02895 |
| Pamela M Arway |
director |
601 HAWAII ST., EL SEGUNDO CA 90245 |
| Gregory J. Moore |
director |
130 EAST RANDOLPH STREET, SUITE 1000, CHICAGO IL 60601 |
DaVita (DaVita) Headlines
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
DVA has been successfully added to your